Coherus Oncology hires Oppenheimer to sell biosimilar assets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Coherus Oncology hires Oppenheimer to sell biosimilar assets

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

September 23, 2026 9:30 AM EDT

REDWOOD CITY, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today announced that it has initiated the process to market and sell the remaining assets associated with the Companys former biosimilars business (the Legacy BioSim Assets). The Company has retained Oppenheimer & Co. Inc. (Oppenheimer) to serve as its financial advisor in connection with the sale. Parties interested in the opportunity should direct inquiries to the Oppenheimer contacts listed below.

We are pleased to be working with a bank of Oppenheimers caliber to market our legacy... More